Daniel Ludwig wanted to bring together the best minds and the best resources, wherever they are, to tackle cancer.
Ludwig is at the forefront of developing ways to boost the immune system's ability to fight tumors.
Ludwig research on the prevalence of HPV among men leads to a change in US public health policy.
Blocking interleukin-11 signaling could provide new approach for the treatment of bowel and stomach cancers.
Findings from Ludwig Stockholm study provide clues for improved treatments for neuroblastoma.
Meet our scientists